drugset / Trial / NCT06594159

A Study of LY4065967 in Healthy Japanese Participants

NCT06594159 ↗

Phase 1 Completed 59 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindBasic science

Summary

The purpose of this study is to obtain safety and tolerability data of the study drug known as LY4065967 and rosuvastatin in healthy Japanese participants. Blood tests will be performed to check how much LY4065967 and rosuvastatin get into the bloodstream and how long it takes the body to eliminate it. This is a 3-part study and will last approximately 2 weeks excluding screening period for each part.

Timeline

Start
2024-10-22
Primary completion
2025-03-11
Completion
2025-03-11

Drugs

EvaluationDrugModalityDoseRoute
Subject LY4065967 Unknown — Oral
Subject Rosuvastatin Small molecule — Oral

Indications

No indication recorded.